{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:34:35Z","timestamp":1784194475480,"version":"3.55.0"},"reference-count":31,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,5,7]],"date-time":"2002-05-07T00:00:00Z","timestamp":1020729600000},"content-version":"vor","delay-in-days":36,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Transplantation"],"published-print":{"date-parts":[[2002,4]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold>Cytomegalovirus (CMV) is the most important opportunistic infection in renal transplant recipients and is associated with an increased risk of rejection. Infection can be acquired post\u2010operatively (from the transplanted organ) or from re\u2010activation of latent disease. To identify risk factors for CMV disease in a pediatric population within 1\u2003yr of renal transplant, and to generate hypotheses for the pathogenesis of CMV disease in this population, a review of all recipients from 1992 to 1998 in a children's hospital in Atlanta, Georgia, was undertaken. Medical records of 73 transplants performed on 72 patients were reviewed: nine (12.7%) of 72 individuals, after 73 procedures developed CMV disease. Median time to onset of CMV disease was 52\u2003days post\u2010transplant (range = 15\u201395\u2003days). Receipts of mycophenolate mofetil (MMF), demographic factors, and use of cadaveric kidneys were not associated with a significantly elevated risk of CMV disease. Positive donor CMV serostatus was associated with CMV disease (uni\u2010variate relative risk [RR]\u2003=\u20038.52, Fisher's Exact Test [FET] p =\u200a0.010). Patients with transplants in October or November had a higher risk of developing CMV disease (four of 13; 30.8%) than patients transplanted in other months (five of 60, 8.3%); RR\u2003=\u20033.69; p =\u200a0.047, FET). Most transplants of patients who did not develop CMV disease were performed in January through August (48\/64; 75.0%); only 25.0% were performed in September through December. In contrast, six of nine (66.7%) transplants in patients who subsequently developed CMV disease were performed in September through December (p =\u200a0.018, FET). Donor CMV\u2010positive serostatus and transplant in October and November continued to be independently associated with an increased risk of CMV disease when controlled for other factors. The association of transplant in October and November with CMV disease in November\u2013January may be related to an increased risk of seasonal community CMV exposure and primary CMV infection during the peak season for CMV circulation, with subsequent immune suppression promoting progression to disease. Alternatively, co\u2010infection with seasonal pathogens after exposure from an infected donor during the period of immune suppression may promote progression from CMV infection to CMV disease. Further studies should be undertaken to explore these and other hypotheses, which may have implications for determination of a need for anti\u2010viral prophylaxis.<\/jats:p>","DOI":"10.1034\/j.1399-3046.2002.01049.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T18:58:38Z","timestamp":1047495518000},"page":"111-118","source":"Crossref","is-referenced-by-count":35,"title":["Predictors of cytomegalovirus disease among pediatric transplant recipients within one year of renal transplantation"],"prefix":"10.1034","volume":"6","author":[{"given":"Lisa\u2010Gaye","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Hilinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fitzroy","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Hymes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo M.","family":"Beck\u2010Sague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Nesheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,5,7]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199304000-00032"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004670050361"},{"key":"e_1_2_7_4_2","first-page":"143","volume-title":"Antiviral Chemotherapy.","author":"Zaia J","year":"1996"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(98)00433-3"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.4.1014"},{"key":"e_1_2_7_7_2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1399-0012.1996.tb00659.x","article-title":"Mycophenolate mofetil for maintenance therapy in kidney transplantation","volume":"10","author":"Gonwa T","year":"1996","journal-title":"Clin Transpl"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000190219"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1399-0012.1998.tb01091.x","article-title":"Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses","volume":"12","author":"Moreso F","year":"1998","journal-title":"Clin Transpl"},{"key":"e_1_2_7_10_2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1399-0012.1996.tb00659.x","article-title":"Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation?","volume":"10","author":"Sarmiento JM","year":"1996","journal-title":"Clin Transpl"},{"key":"e_1_2_7_11_2","first-page":"233","volume-title":"Multidisci\u2010plinary Approach to Understanding Cytomegalovirus Disease.","author":"Ljungman P","year":"1993"},{"key":"e_1_2_7_12_2","first-page":"3473","article-title":"Cytomegalo\u2010virus prophylaxis in antibody\u2010treated renal transplanted patients","volume":"27","author":"Birkeland S","year":"1995","journal-title":"Transplant Proc"},{"key":"e_1_2_7_13_2","volume-title":"Epi Info 2000: A Database and Statistics Program for Public Health Professionals for Use on Windows 95, 98, NT, and 2000 Computers.","author":"Dean AG","year":"2000"},{"key":"e_1_2_7_14_2","volume-title":"SAS\/STAT Software: Changes and Enhance\u2010ments.","author":"SAS Institute Inc","year":"1997"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00861569"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/515383"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199905133401903"},{"key":"e_1_2_7_18_2","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1681\/ASN.V991697","article-title":"Clinical practice guidelines: prevention of cytomegalovirus disease after renal transplantation","volume":"9","author":"Jassal S","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1995.01430110075014"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199605150-00001"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199403270-00019"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199855010-00005"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365549850160837"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/56.18.1831"},{"key":"e_1_2_7_25_2","first-page":"373","article-title":"Viruses associated with acute lower respiratory tract infections in children from the eastern highlands of Papua New Guinea (1983\u20131985)","volume":"21","author":"Phillips P","year":"1990","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.68.3.408"},{"key":"e_1_2_7_27_2","first-page":"21","article-title":"A review of reported cytomegalovirus infections in Scotland during 1975","volume":"35","author":"Russell HB","year":"1977","journal-title":"Health Bull"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890350105"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1999.tb01286.x"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(99)80084-4"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-1702(97)00100-7"},{"key":"e_1_2_7_32_2","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1128\/jvi.65.6.2895-2902.1991","article-title":"Transactivation of the human immunodeficiency virus promoter by human herpesvirus 6 (HHV\u20106) strains GS and Z\u201029 in primary human T lymphocytes and identification of transactivating HHV\u20106(GS) gene fragments","volume":"65","author":"Horvat RT","year":"1991","journal-title":"J Virol"}],"container-title":["Pediatric Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-3046.2002.01049.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1399-3046.2002.01049.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T10:27:19Z","timestamp":1733567239000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1399-3046.2002.01049.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["10.1034\/j.1399-3046.2002.01049.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1399-3046.2002.01049.x","archive":["Portico"],"relation":{},"ISSN":["1397-3142","1399-3046"],"issn-type":[{"value":"1397-3142","type":"print"},{"value":"1399-3046","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}